Immunotherapy, especially immune checkpoint inhibitors (such as PD-1/PD-L1 and CTLA-4 inhibitors), further enhances the efficacy of radiotherapy by lifting the tumor’s suppression of the immune system. Here, CTLA4 is linked to neoplasm.